Hunger hormone-based therapy for lowering cholesterol, and triglycerides levels: Ghrelin, a digestive hormone that controls appetite, decreases the levels of HMGCR,  triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD), via up-regulation of its target gene, 27/April/2019, 11.57 pm